Pharma & Biotech Patent Litigation Conference

Sterne Kessler’s Paul Ainsworth spoke at the Pharma & Biotech Patent Litigation Conference hosted by Kiasco Research in Amsterdam, Netherlands. Paul participated in the panel “Preliminary Injunction Review for the Life Science Sector,” where he and the other panelists delivered a strategic overview of recent developments in preliminary injunctions across the UPC, Europe, and the United States, helping patent holders and challengers alike prepare for high-stakes enforcement. The discussion also unpacked emerging trends, legal thresholds, and jurisdictional contrasts shaping the availability and strength of injunctive relief.

Topics Included:

• Explore the latest PI case law from the UPC, key EU countries, and the USA, and how it impacts pharma and biotech strategies.
• Understand practical approaches for securing or resisting injunctions in different jurisdictions, including timing, evidence, and risk assessment.
• Gain actionable insights on how PI outcomes are influencing broader litigation and market entry planning in the life sciences.